Medistim ASA (STO:MEDIO)

Market Cap	3.68B +21.4%
Revenue (ttm)	639.83M +25.8%
Net Income	145.57M +53.3%
EPS	7.96 +53.6%
Shares Out	n/a
PE Ratio	25.26
Forward PE	24.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7
Average Volume	1,285
Open	202.00
Previous Close	n/a
Day's Range	202.00 - 202.00
52-Week Range	154.00 - 284.00
Beta	n/a
RSI	41.35
Earnings Date	Feb 27, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MEDIO

Financial Performance

In 2025, Medistim ASA's revenue was 699.77 million, an increase of 25.82% compared to the previous year's 556.16 million. Earnings were 159.21 million, an increase of 53.33%.

Financial numbers in NOK